Inactive Instrument

Other languages Opko Health Inc. Nyse

Equities

US68375N1037

End-of-day quote Nyse Other stock markets
- ^USD	-

Mar. 28	Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets	MT
Mar. 20	Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets	Mar. 28
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome	Mar. 20
Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing	Mar. 14
Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing	Mar. 13
Opko Health Insider Bought Shares Worth $559,380, According to a Recent SEC Filing	Mar. 12
OPKO Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27
Drugmakers deepen efforts to tap into booming market for obesity drugs	Feb. 27
Opko Health Insider Bought Shares Worth $991,700, According to a Recent SEC Filing	Feb. 21
OPKO Health, Inc. Announces the Cessation of Alexis Borisy as Member of the Board of Directors and Member of Compensation Committee of the Board	Feb. 09
NextPlat Preparing to Launch Opko Health Store on Alibaba's Tmall Global Platform	Feb. 05
Opko Health Insider Bought Shares Worth $488,650, According to a Recent SEC Filing	Jan. 19
Opko Health Insider Bought Shares Worth $386,200, According to a Recent SEC Filing	Jan. 18
Opko Health Insider Bought Shares Worth $954,300, According to a Recent SEC Filing	Jan. 16
Opko Health Insider Bought Shares Worth $480,379, According to a Recent SEC Filing	Jan. 11
OPKO Health Closes Private Offering of $230 Million Convertible Notes Due 2029	Jan. 09
USA: 1000 Dollar monatlich für Anti-Adipositas-Behandlung	Jan. 09
Opko Health Insider Bought Shares Worth $1,344,600, According to a Recent SEC Filing	Jan. 08
Kosten van een obesitasbehandeling in de VS: 1000 USD per maand	Jan. 07
Opko Health Insider Bought Shares Worth $514,093, According to a Recent SEC Filing	Jan. 05
OPKO Health Prices $200 Million Convertible Senior Notes Offering	Jan. 05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Opko Health Inc. Nyse

Equities

US68375N1037

Other languages

Filters